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May 26, 2009:2010–3itamin D Deficiency
nd Myocardial Dysfunction
n a recent review, Lee et al. (1) have outlined the role of vitamin
deficiency as a cardiovascular risk factor. In this letter, we want
o point out that direct effects of vitamin D on the myocardium
ight partially explain the link between vitamin D deficiency
nd adverse cardiovascular outcome. This notion is supported
y observations that human cardiomyocytes express enzymes for the
etabolism of vitamin D as well as a functional vitamin D receptor,
hich is up-regulated in myocardial hypertrophy (2,3). In animal
odels of heart failure, active vitamin D treatment was shown to
educe cardiac hypertrophy and to attenuate myocardial dysfunction
4). Several genes that are up-regulated in the course of cardiac
ypertrophy, involving those of natriuretic peptides and renin, are
own-regulated by vitamin D (4). Importantly, there exists increasing
olecular and clinical evidence that a sufficient vitamin D status is
equired for maintenance of diastolic function of the heart (3,4).
urthermore, there are several case reports of vitamin D–deficient
hildren with dilated cardiomyopathy that could be successfully
reated with vitamin D and calcium (5). In line with this are data from
cohort of over 3,000 patients referred for coronary angiography that
howed a significant association of vitamin D deficiency with reduced
eft ventricular function (6). In the same study cohort, vitamin D
eficiency was prospectively associated with deaths caused by heart
ailure and with sudden cardiac deaths (6). These results fit well with
bservations that active vitamin D treatment in hemodialysis patients
as shown to regress cardiac hypertrophy and to reduce QT interval
nd dispersion (4,7). In conclusion, there exists compelling evidence
hat vitamin D supplementation might be useful for the prevention
nd treatment of myocardial diseases.
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itamin D, Outdoor Happiness,
nd the Meaning of Deficiency
ee et al. (1) informatively review the emerging evidence for
itamin D as a lifestyle risk factor for cardiovascular disease. Two
verlooked points should be highlighted. First, as the investigators
ote, the great majority of vitamin D is derived from sun exposure,
ather than dietary consumption. Thus, effect estimates in studies
f vitamin D levels and cardiovascular risk may be confounded, at
east in part, by challenging-to-measure differences in lifestyles,
ehaviors, dispositions, and opportunities that lead individuals to
njoy and spend time in the sun, such as physical and social
ctivities. Whereas vitamin D itself may still provide benefit, being
utside and enjoying these activities are likely to provide additional
ealth benefits that erroneously may be attributed as effects of
itamin D.
Second, vitamin D deficiency has become popularly (and
ariably) defined by suppression of counter-regulatory hormone
evels or by risk of chronic disease, resulting in remarkably high
roportions or even majorities of healthy populations being defined
s deficient (2,3). Even if vitamin D is convincingly determined to
revent cardiovascular disease or cancer, as may be quite plausible,
he departure of such metrics from more typical definitions of
eficiency (4) based on prevention of overt deficiency symptoms or
omparable biologic indicators must be explicitly recognized. Such
ovel definitions of deficiency could be arguably justified to reduce
isk of chronic disease in the population because policy makers,
ealth providers, and the public each seem to respond much more
rgently to concerns over individuals having deficient versus
uboptimal exposures. Based on this same logic, however, the
trength, consistency, and breadth of scientific evidence would
rgue for highlighting more strongly the current worldwide pan-
emics of omega-3 deficiency, whole-grain deficiency, vegetable
eficiency, and physical activity deficiency, among others. For
xample, long-chain omega-3 fatty acids have robust associations
ith lower risk of coronary heart disease death in numerous
ell-performed observational studies, including 16 prospective
ohort studies of 326,572 generally healthy individuals from the
.S., Europe, and Asia; significant cardiovascular benefits in 4 of
large randomized controlled trials of dietary or supplement
mega-3s in 36,431 patients with and without established heart
isease; and 10-fold differences in risk of sudden cardiac death
ith modest differences in circulating blood levels (5). At a time
hen the Institute of Medicine is being urged to revise dietary
equirements for vitamin D based on novel definitions of defi-
iency, these considerations and comparisons cannot be over-
ooked.
